Joel S.Schuman, MD

An Evening of BrightFocus: June 6, 2019

Joel Schuman, MD, FACS
Joel S. Schuman, MD, FACS, of New York University (NYU) Langone Eye Center, is one of the world’s leading ophthalmologists specializing in glaucoma and diagnostic testing of eye disease. With early funding from BrightFocus, Dr. Schuman made groundbreaking discoveries on the genetics of glaucoma. He and his colleagues were the first to identify a molecular marker for human glaucoma. He was a co-inventor of the optical coherence tomography (OCT) imaging technology. The invention of the OCT has revolutionized vision care, allowing for early detection and treatment of diseases such as glaucoma and macular degeneration.

Dr. Schuman is Director of the NYU Langone Eye Center; Professor and Chairman of Ophthalmology and Professor of Neuroscience and Physiology and a member of the Neuroscience Institute at NYU Langone Medical Center, NYU School of Medicine; Professor of Biomedical, Electrical and Computer Engineering at NYU Tandon School of Engineering; and Professor of Neural Science at the Center for Neural Science at NYU.

Prior to arriving at NYU in 2016, he was Distinguished Professor and Chairman of Ophthalmology, Eye and Ear Foundation Endowed Chair in Ophthalmology, and Director of the University of Pittsburgh UPMC Eye Center (2003-2016). Before that he was at Tufts University (1991-2003), where he was Residency Director and Glaucoma and Cataract Service Chief, and then Professor of Ophthalmology. He was Vice Chair in 2001 at New England Eye Center. Dr. Schuman has published more than 350 peer-reviewed scientific journal articles, was elected to the American Ophthalmological Society and the American Association of Physicians, and has received numerous awards and recognitions from his peers.

Don't miss out.
Receive research updates, inspiring stories, and expert advice
Keep me informed about: *
Please select at least one.
You must select at least one disease category.
Please enter your first name.
Please enter your last name.